A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies

S Goel, A. C Mita, M Mita, E. K Rowinsky, Q. S Chu, N Wong, C Desjardins, F Fang, M Jansen, D. E Shuster, S Mani and C. H. Takimoto

Clinical Cancer Research 15 ( 12 ): 4207 - 4212 , 2009